188260 — Sanigen Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Sanigen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	—	—	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	23,487	25,221	26,758	22,268	24,010
Cost of Revenue
Gross Profit	3,525	3,615	3,896	3,039	3,194
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	25,542	28,088	30,837	28,585	29,114
Operating Profit	-2,055	-2,867	-4,079	-6,316	-5,104
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,593	-4,281	-4,065	-8,833	-5,062
Provision for Income Taxes
Net Income After Taxes	-2,593	-4,281	-4,065	-8,775	-5,070
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,595	-4,281	-4,065	-8,775	-5,070
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,595	-4,281	-4,065	-8,775	-5,070
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-425	-641	-607	-1,722	-728
Dividends per Share